Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
British Journal of Haematology
|
June 18, 2010
The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study
Stephen A Schey, Gareth J Morgan, Karthik Ramasamy, et al.
Leukemia & Lymphoma
|
February 7, 2009
The impact of extramedullary disease at presentation on the outcome of myeloma
Ping Wu, Faith E Davies, Kevin Boyd, et al.
Pediatric Quality & Safety
|
April 8, 2024
Quality Improvement Project to Improve the Timeliness of Care for Children With Testicular Torsion in the Emergency Department
Sri S Chinta, Matthew P Gray, Matthew Kopetsky, et al.
Haematologica
|
December 10, 2020
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial
Charlotte Pawlyn, David Cairns, Tom Menzies, et al.
Experimental Gerontology
|
September 1, 2020
Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespan
Mi-Jung Kim, Chul Han, Karessa White, et al.
Blood
|
April 28, 2010
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
Tina Bagratuni, Ping Wu, David Gonzalez de Castro, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2021
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial
Sarah Bird, David Cairns, Tom Menzies, et al.
Elife
|
April 12, 2017
A metabolic switch controls intestinal differentiation downstream of <i>Adenomatous</i> polyposis coli (APC)
Imelda T Sandoval, Richard Glenn C Delacruz, Braden N Miller, et al.
British Journal of Sports Medicine
|
June 18, 2016
Injury and illness in aquatic sport: how high is the risk? A comparison of results from three FINA World Championships
Annika Prien, Margo Mountjoy, Jim Miller, et al.
British Journal of Haematology
|
June 16, 2026
Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial
Andrew Hall, James Croft, Katrina Walker, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
British Journal of Haematology
|
June 18, 2010
The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study
Stephen A Schey, Gareth J Morgan, Karthik Ramasamy, et al.
Leukemia & Lymphoma
|
February 7, 2009
The impact of extramedullary disease at presentation on the outcome of myeloma
Ping Wu, Faith E Davies, Kevin Boyd, et al.
Pediatric Quality & Safety
|
April 8, 2024
Quality Improvement Project to Improve the Timeliness of Care for Children With Testicular Torsion in the Emergency Department
Sri S Chinta, Matthew P Gray, Matthew Kopetsky, et al.
Haematologica
|
December 10, 2020
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial
Charlotte Pawlyn, David Cairns, Tom Menzies, et al.
Experimental Gerontology
|
September 1, 2020
Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespan
Mi-Jung Kim, Chul Han, Karessa White, et al.
Blood
|
April 28, 2010
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
Tina Bagratuni, Ping Wu, David Gonzalez de Castro, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2021
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial
Sarah Bird, David Cairns, Tom Menzies, et al.
Elife
|
April 12, 2017
A metabolic switch controls intestinal differentiation downstream of <i>Adenomatous</i> polyposis coli (APC)
Imelda T Sandoval, Richard Glenn C Delacruz, Braden N Miller, et al.
British Journal of Sports Medicine
|
June 18, 2016
Injury and illness in aquatic sport: how high is the risk? A comparison of results from three FINA World Championships
Annika Prien, Margo Mountjoy, Jim Miller, et al.
British Journal of Haematology
|
June 16, 2026
Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial
Andrew Hall, James Croft, Katrina Walker, et al.
Page
of 5